ºÚÁÏÍø has made the decision to cancel its October 2020 conference on Trends in Publicly Sponsored Healthcare, given continuing developments concerning COVID-19 and out of an abundance of caution for the safety of attendees, speakers, and staff. Full refunds will be made to registered attendees and sponsors.
43 Results found.
Early Bird Registration Expires July 29 for HMA Conference, October 26-27 in Chicago
Be sure to register soon for HMA’s conference on What’s Next for Medicaid, Medicare, and Publicly Sponsored Healthcare: How Payers, Providers, and States Are Navigating a Future of Opportunity and Uncertainty, October 26-27, at the Fairmont Chicago, Millennium Park. The Early Bird registration rate of $1595 per person expires on July 29. After that, the rate is $1795.
HMA-developed medications for addiction treatment (MAT) training for justice and child welfare now available online
Focused on ongoing support and solutions for those living with opioid use disorder (OUD), ºÚÁÏÍø (HMA) has developed a robust web-based training program about addiction and its treatment in the criminal justice and child welfare systems, including access to, and continued use of, medications for addiction treatment (MAT).
Optimizing buprenorphine prescribing capacity in jails and prisons
This week, our In Focus section discusses an issue brief prepared by ºÚÁÏÍø (HMA), Optimizing Capacity for Prescribing Buprenorphine in Jails and Prisons, authored by HMA Principals Shannon Robinson, MD and Donna Strugar-Fritsch, BSN, MPA, CCHP.
Webinar alert: Evidence-based treatment of opioid use disorder in correctional settings
HMA is cohosting a webinar with the
Opioid use disorder is a chronic brain disease with effective, evidence-based treatments, and is a condition protected by the Americans with Disabilities Act. Prisons and jails are expected, by national health care and justice organizations and by communities, to treat incarcerated persons with OUD in accordance with evidence-based practices. This webinar reviews the most current evidence-based care for opioid withdrawal and OUD treatment and provides clinicians with strategies to move correctional health practices into compliance with national and community standards.
HMA conference on trends in publicly sponsored healthcare
HMA Conference 2020
What’s Next for Medicaid, Medicare, and Publicly Sponsored Healthcare:
How Payers, Providers, and States Are Navigating a Future of Opportunity and Uncertainty
Pre-Conference Workshop: October 25
Conference: October 26-27
Location: Fairmont Chicago, Millennium Park
HMA to lead jail-based opioid response program in Pennsylvania
In the nationwide effort to combat opioid use disorder (OUD), ºÚÁÏÍø (HMA) is expanding its successful Medications for Opioid Use Disorder (MOUD) initiative to jails in Pennsylvania counties. The multi-tiered technical assistance approach, developed by HMA and implemented in the California correctional system, works to combat opioid overdoses by expanding access to treatment for OUD in jails and prisons.